The contribution of VHL substrate binding and HIF1-α to the phenotype of VHL loss in renal cell carcinoma
✍ Scribed by Jodi K Maranchie; James R Vasselli; Joseph Riss; Juan S Bonifacino; W.Marston Linehan; Richard D Klausner
- Book ID
- 114413163
- Publisher
- Elsevier Science
- Year
- 2002
- Tongue
- English
- Weight
- 415 KB
- Volume
- 1
- Category
- Article
- ISSN
- 1535-6108
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Human renal cell carcinoma (RCC) is a common malignant disease of the kidney characterized by dedifferentiation of renal epithelial cells. Our previous experiments showed that most RCCs have a loss of function of the tissue-specific transcription factor hepatocyte nuclear factor (HNF) 1α. Detailed a
## Communicated by Albert de la Chapelle To investigate the nature of somatic von Hippel-Lindau (VHL) mutations, we analyzed 173 primary sporadic human renal cell carcinomas for mutations of the VHL tumor suppressor gene, using polymerase chain reaction (PCR) and single-strand conformational polym
Inactivation of tumour suppressor gene(s) (TSGs) on 3p appears to be a critical event in the pathogenesis of clear cell renal cell carcinoma (CC-RCC). Analysis of loss of heterozygosity (LOH) in sporadic RCC samples has implicated roles for TSGs in three specific regions of 3p in RCC development: (1